Related Experiment Videos
Percutaneous biliary metal wall stenting in malignant obstructive jaundice
Adrian A Indar1, Dileep N Lobo, Andrew D Gilliam
1Section of Surgery, University Hospital Nottingham NHS Trust, Nottingham, UK.
European Journal of Gastroenterology & Hepatology
|July 18, 2003
Summary
Metallic stents offer safe and effective palliation for malignant obstructive jaundice. While improving bilirubin levels, overall survival remains poor due to disease progression, highlighting the need to identify suitable patients.
Area of Science:
- Gastroenterology
- Interventional Radiology
- Oncology
Background:
- Malignant obstructive jaundice often requires palliative care.
- Metallic stents are a safe, effective, and minimally invasive option for palliation.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneous metallic Wallstent insertion for malignant obstructive jaundice.
- To analyze patient survival and complication rates following biliary stenting.
Main Methods:
- Retrospective review of case notes for 89 patients undergoing percutaneous biliary metal stent insertion between January 1996 and December 2000.
- Analysis of diagnoses, complication rates, hospital stay, readmissions, symptom-free period, and survival.
Main Results:
- 96% of patients achieved normal bilirubin levels within one month.
- Median survival was 3.5 months; survival correlated inversely with pre-stenting serum bilirubin.
- Early complications occurred in 30% of patients, with a 30-day mortality rate of 20%.
Conclusions:
- Metallic stenting provides effective palliation for malignant obstructive jaundice with low procedure-related risks.
- Disease-related morbidity significantly impacts overall survival.
- Further research is needed to identify patients who may not benefit from stenting.